Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Invested Capital (2016 - 2025)

Historic Invested Capital for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $65.2 million.

  • Fortress Biotech's Invested Capital rose 61173.65% to $65.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.2 million, marking a year-over-year increase of 61173.65%. This contributed to the annual value of $22.7 million for FY2024, which is 85.61% up from last year.
  • Latest data reveals that Fortress Biotech reported Invested Capital of $65.2 million as of Q3 2025, which was up 61173.65% from $43.9 million recorded in Q2 2025.
  • Fortress Biotech's Invested Capital's 5-year high stood at $248.3 million during Q2 2021, with a 5-year trough of -$15.9 million in Q2 2023.
  • For the 5-year period, Fortress Biotech's Invested Capital averaged around $82.6 million, with its median value being $43.9 million (2025).
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 11987.78% in 2024, then skyrocketed by 92514.61% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Invested Capital stood at $225.9 million in 2021, then tumbled by 77.85% to $50.0 million in 2022, then tumbled by 54.93% to $22.5 million in 2023, then rose by 0.86% to $22.7 million in 2024, then skyrocketed by 186.69% to $65.2 million in 2025.
  • Its Invested Capital was $65.2 million in Q3 2025, compared to $43.9 million in Q2 2025 and $32.5 million in Q1 2025.